The Patent Finder
US

Nucleoside Derivatives as Inhibitors of RNA-Dependent RNA Viral Polymerase

US 7,125,855 Expired (term)
OverviewFamilyAssignmentsSources & methods

Also listed on Merck Sharp & Dohme LLC, which filed it. The recorded assignments below show how it moved.

Expired Jun 17, 2022 · High confidence

Held by Merck Sharp & Dohme LLC
Filed Oct 17, 2003 · Granted Oct 24, 2006
Base term plus 413 days of PTA · capped by a resolved terminal disclaimer
Today
20 years from filing
Term ended Jun 17, 2022
2002 2026
Clock starts
Jan 18, 2002
Term ended
Jun 17, 2022
Granted
Oct 24, 2006
base term patent term adjustment after the term ends fee events Updated Nov 1, 2026 · includes USPTO assignment & status data published Nov 1, 2026 and grant & fee data published Oct 27, 2026 (weekly) · how we know
413
Days of term adjustment
Read from the USPTO PTA record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 6,777,395.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
14
Applications in this family
Applications sharing this one's continuity chain.

This patent's term runs 413 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. All three maintenance fees were paid, so no fee lapse ended it. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jan 18, 2002Jan 18, 2022High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+413 days, USPTO PTA recordMar 7, 2023High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 6,777,395)capped to Jun 17, 2022High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidExpired (term)High confidence
Computed term endThe steps above, in orderJun 17, 2022High confidence

This family

US 6,777,395Expired (term)
Jun 2022
Jun 2022
Application PCT/US2002/003086Pending
not computed
not computed
Application PCT/US2002/001531PCT application
no patent term
no patent term
US 7,125,855this patent
Jun 2022
Jun 2022
US 7,105,499Expired (term)
Dec 2022
Dec 2022
US 7,202,224Expired (term)
Jan 2022
Jan 2022
Application 11/643,464Abandoned
not computed
not computed
US 8,481,712In force
Jan 2027
Jan 2027
8 of 14 applications in this family shown, earliest filings first.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 28, 2010
Reel 23861, frame 349
Merck & Co., Inc.Merck Sharp & Dohme Corp.Change of Name
Aug 27, 2012
Reel 28850, frame 515
Merck Sharp & Dohme Corp.Schering CorporationMerger
Aug 29, 2012
Reel 28866, frame 511
Schering CorporationMerck Sharp & Dohme Corp.Change of Name
Jul 26, 2017
Reel 43341, frame 571
Isis Pharmaceuticals, Inc.Ionis Pharmaceuticals, Inc.Change of Name
Aug 8, 2022
Reel 61102, frame 145
Merck Sharp & Dohme Corp.Merck Sharp & Dohme LLCMerger

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

Maintenance fee events come from USPTO's own fee records. USPTO does not publish a per-patent fee page, so there is nothing to link to.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.

What's changing

Note
The 413 days of PTA are read from the USPTO record, not recalculated by us
Disclaimer cap

This term is capped by a terminal disclaimer resolved from the filed document, referencing US 6,777,395.

Citations

463
later US patents cite this one
That is top 1% of utility patents granted in 2006 in our data, the only group it is compared against. How we rank
Every date shows its work: base rule, PTA, PTE, disclaimer caps, fee overlay, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 1, 2026 · includes USPTO assignment & status data published Nov 1, 2026 and grant & fee data published Oct 27, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited